Regenerative Medicine at Joint Preservation Congress for Third Year

This year again, Lipogems technology, patented by Prof. Tremolada, is featured at the world congress on joint preservation research, with particular focus on hip, foot, and knee conditions.

VI Joint Preservation Congress - Warsaw

For the third year, Prof. Tremolada returns to Warsaw to participate in the world congress. Most treatments used for degenerative diseases are unable to maintain full joint functionality and physical fitness in patients. With the increase in these conditions, increasingly affecting younger patients, professionals worldwide seek effective alternative treatments. The objective is to reduce patient pain and extend physical activity. The congress features leading international experts - prominent physicians and scientists including Prof. Carlo Tremolada - a leader in research, development, and application of new technologies for treating degenerative diseases and related trauma.

Joint Preservation with Lipogems

"I always aim to convey this new concept of regeneration. Lipogems is not stem cells, not nanofat, not a mechanically obtained SVF. Lipogems is a method for mechanically expanding the functional surface of adipose tissue through micro-fragmentation within a closed system. Lipogems not only improves vascular density but also initiates and significantly accelerates the natural healing process. With Lipogems, you heal like a child... You heal naturally."

Lipogems represents the simplest, fastest, and safest system for injury recovery and healing. Patients with articular cartilage lesions experience pain and reduced functionality, often progressing to osteoarthritis, one of the top ten causes of disability worldwide. Lipogems dramatically accelerates the natural tissue regeneration and repair process. Through Lipogems, it's possible to conservatively treat various pathologies with exceptional results, including degenerative arthrosis affecting joints (shoulders, knees, ankles, hip) and more.